Skip to content

A Pilot Clinical Trial to Determine the Feasibility of Administering an Electronic Tool to Assess Postoperative pAin, Nausea, and Vomiting in English or Spanish-Speaking Pediatric Patients With Neoplastic Conditions.

A Pilot Clinical Trial to Determine the Feasibility of Administering an Electronic Tool to Assess Postoperative pAin, Nausea, and Vomiting in English or Spanish-Speaking Pediatric Patients With Neoplastic Conditions.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05933252
Enrollment
14
Registered
2023-07-06
Start date
2023-06-19
Completion date
2025-04-21
Last updated
2025-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplastic Conditions

Brief summary

The feasibility of using an electronic tool to measure pain, nausea, and vomiting after surgery in English or Spanish-speaking pediatric cancer patients.

Detailed description

Primary Objective: To determine the feasibility of administering an AR-based electronic tool to assess postoperative pain, nausea, and vomiting in English or Spanish-speaking pediatric patients with neoplastic conditions. Secondary Objectives: 1. To evaluate the willingness to use the AR app, 2. To evaluate the time spent using the AR app (recorded in the study device), 3. To calculate the difference (delta) between pain and nausea intensity recorded from the app and those gathered by nursing personnel, 4. To evaluate app recorded responses to pain intensity, 5. To evaluate app recorded responses to nausea intensity, 6. To assess the frequency of vomiting, 7. To measure the length of stay in PACU (calculated from the EMR), 8. To determine the rate (number) of assessments completed, 9. To calculate PACU opioid use, 10. To calculate opioid use during hospitalization, 11. To assess the quality of life using the PedsQL Cancer Module survey responses (administered by the study team), 12. To evaluate patient/caregiver satisfaction following the PACU stay 13. To assess nursing experience with AR tool following patient discharge from PACU. Exploratory Objectives: 1. To assess the primary/secondary outcomes for the English and Spanish-speaking patients separately. 2. To correlate pain-reported intensity to the analgesia nociception index (ANI).

Interventions

an app on an iPad every 15 minutes

Sponsors

National Institute of Drug Abuse
CollaboratorFED
M.D. Anderson Cancer Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
7 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

1. Ages 7-17 years old, 2. Able to provide assent, and a legal guardian able to provide informed consent 3. Current diagnosis of pediatric cancer or benign neoplasm, 4. Surgery with an estimated duration longer than 2 hours, 5. An expected prescription of opioids during the inpatient perioperative period 6. Demonstrate capacity to comprehend and interact with the game in English or Spanish.

Exclusion criteria

1. Any concerns from the principal investigator or primary team about the use of the app, 2. Inability or refusal from the parents to provide written informed consent.

Design outcomes

Primary

MeasureTime frame
Activation and use of the technology (YES versus NO)through study completion; an average of 1 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026